Effect of Ciprofloxacin-Loaded Niosomes on <i>Escherichia coli</i> and <i>Staphylococcus aureus</i> Biofilm Formation

Infections caused by bacterial biofilms represent a global health problem, causing considerable patient morbidity and mortality in addition to an economic burden. <i>Escherichia coli</i>, <i>Staphylococcus aureus,</i> and other medically relevant bacterial strains colonize cl...

Full description

Bibliographic Details
Main Authors: Linda Maurizi, Jacopo Forte, Maria Grazia Ammendolia, Patrizia Nadia Hanieh, Antonietta Lucia Conte, Michela Relucenti, Orlando Donfrancesco, Caterina Ricci, Federica Rinaldi, Carlotta Marianecci, Maria Carafa, Catia Longhi
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/12/2662
_version_ 1797455702141173760
author Linda Maurizi
Jacopo Forte
Maria Grazia Ammendolia
Patrizia Nadia Hanieh
Antonietta Lucia Conte
Michela Relucenti
Orlando Donfrancesco
Caterina Ricci
Federica Rinaldi
Carlotta Marianecci
Maria Carafa
Catia Longhi
author_facet Linda Maurizi
Jacopo Forte
Maria Grazia Ammendolia
Patrizia Nadia Hanieh
Antonietta Lucia Conte
Michela Relucenti
Orlando Donfrancesco
Caterina Ricci
Federica Rinaldi
Carlotta Marianecci
Maria Carafa
Catia Longhi
author_sort Linda Maurizi
collection DOAJ
description Infections caused by bacterial biofilms represent a global health problem, causing considerable patient morbidity and mortality in addition to an economic burden. <i>Escherichia coli</i>, <i>Staphylococcus aureus,</i> and other medically relevant bacterial strains colonize clinical surfaces and medical devices via biofilm in which bacterial cells are protected from the action of the immune system, disinfectants, and antibiotics. Several approaches have been investigated to inhibit and disperse bacterial biofilms, and the use of drug delivery could represent a fascinating strategy. Ciprofloxacin (CIP), which belongs to the class of fluoroquinolones, has been extensively used against various bacterial infections, and its loading in nanocarriers, such as niosomes, could support the CIP antibiofilm activity. Niosomes, composed of two surfactants (Tween 85 and Span 80) without the presence of cholesterol, are prepared and characterized considering the following features: hydrodynamic diameter, ζ-potential, morphology, vesicle bilayer characteristics, physical-chemical stability, and biological efficacy. The obtained results suggest that: (i) niosomes by surfactants in the absence of cholesterol are formed, can entrap CIP, and are stable over time and in artificial biological media; (ii) the CIP inclusion in nanocarriers increase its stability, with respect to free drug; (iii) niosomes preparations were able to induce a relevant inhibition of biofilm formation.
first_indexed 2024-03-09T15:58:07Z
format Article
id doaj.art-239a3d44cfca4a97a59ac290cbfa25c4
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T15:58:07Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-239a3d44cfca4a97a59ac290cbfa25c42023-11-24T17:19:49ZengMDPI AGPharmaceutics1999-49232022-11-011412266210.3390/pharmaceutics14122662Effect of Ciprofloxacin-Loaded Niosomes on <i>Escherichia coli</i> and <i>Staphylococcus aureus</i> Biofilm FormationLinda Maurizi0Jacopo Forte1Maria Grazia Ammendolia2Patrizia Nadia Hanieh3Antonietta Lucia Conte4Michela Relucenti5Orlando Donfrancesco6Caterina Ricci7Federica Rinaldi8Carlotta Marianecci9Maria Carafa10Catia Longhi11Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, Piazzale Aldo Moro, 5-00185 Roma, ItalyDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, Piazzale Aldo Moro, 5-00185 Roma, ItalyCentro Nazionale Tecnologie Innovative in Sanità Pubblica, Istituto Superiore di Sanità, Viale Regina Elena, 299-00161 Roma, ItalyDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, Piazzale Aldo Moro, 5-00185 Roma, ItalyDipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, Piazzale Aldo Moro, 5-00185 Roma, ItalyDipartimento di Scienze Anatomiche, Istologiche, Medico-Legali e dell’Apparato locomotore, Sapienza Università di Roma, Via Alfonso Borelli, 50-00161 Roma, ItalyDipartimento di Scienze Anatomiche, Istologiche, Medico-Legali e dell’Apparato locomotore, Sapienza Università di Roma, Via Alfonso Borelli, 50-00161 Roma, ItalyDipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università di Milano, Via Fratelli Cervi, 93-20090 Milano, ItalyDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, Piazzale Aldo Moro, 5-00185 Roma, ItalyDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, Piazzale Aldo Moro, 5-00185 Roma, ItalyDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, Piazzale Aldo Moro, 5-00185 Roma, ItalyDipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, Piazzale Aldo Moro, 5-00185 Roma, ItalyInfections caused by bacterial biofilms represent a global health problem, causing considerable patient morbidity and mortality in addition to an economic burden. <i>Escherichia coli</i>, <i>Staphylococcus aureus,</i> and other medically relevant bacterial strains colonize clinical surfaces and medical devices via biofilm in which bacterial cells are protected from the action of the immune system, disinfectants, and antibiotics. Several approaches have been investigated to inhibit and disperse bacterial biofilms, and the use of drug delivery could represent a fascinating strategy. Ciprofloxacin (CIP), which belongs to the class of fluoroquinolones, has been extensively used against various bacterial infections, and its loading in nanocarriers, such as niosomes, could support the CIP antibiofilm activity. Niosomes, composed of two surfactants (Tween 85 and Span 80) without the presence of cholesterol, are prepared and characterized considering the following features: hydrodynamic diameter, ζ-potential, morphology, vesicle bilayer characteristics, physical-chemical stability, and biological efficacy. The obtained results suggest that: (i) niosomes by surfactants in the absence of cholesterol are formed, can entrap CIP, and are stable over time and in artificial biological media; (ii) the CIP inclusion in nanocarriers increase its stability, with respect to free drug; (iii) niosomes preparations were able to induce a relevant inhibition of biofilm formation.https://www.mdpi.com/1999-4923/14/12/2662niosomesdrug deliveryciprofloxacinanti biofilm activitybladder cells
spellingShingle Linda Maurizi
Jacopo Forte
Maria Grazia Ammendolia
Patrizia Nadia Hanieh
Antonietta Lucia Conte
Michela Relucenti
Orlando Donfrancesco
Caterina Ricci
Federica Rinaldi
Carlotta Marianecci
Maria Carafa
Catia Longhi
Effect of Ciprofloxacin-Loaded Niosomes on <i>Escherichia coli</i> and <i>Staphylococcus aureus</i> Biofilm Formation
Pharmaceutics
niosomes
drug delivery
ciprofloxacin
anti biofilm activity
bladder cells
title Effect of Ciprofloxacin-Loaded Niosomes on <i>Escherichia coli</i> and <i>Staphylococcus aureus</i> Biofilm Formation
title_full Effect of Ciprofloxacin-Loaded Niosomes on <i>Escherichia coli</i> and <i>Staphylococcus aureus</i> Biofilm Formation
title_fullStr Effect of Ciprofloxacin-Loaded Niosomes on <i>Escherichia coli</i> and <i>Staphylococcus aureus</i> Biofilm Formation
title_full_unstemmed Effect of Ciprofloxacin-Loaded Niosomes on <i>Escherichia coli</i> and <i>Staphylococcus aureus</i> Biofilm Formation
title_short Effect of Ciprofloxacin-Loaded Niosomes on <i>Escherichia coli</i> and <i>Staphylococcus aureus</i> Biofilm Formation
title_sort effect of ciprofloxacin loaded niosomes on i escherichia coli i and i staphylococcus aureus i biofilm formation
topic niosomes
drug delivery
ciprofloxacin
anti biofilm activity
bladder cells
url https://www.mdpi.com/1999-4923/14/12/2662
work_keys_str_mv AT lindamaurizi effectofciprofloxacinloadedniosomesoniescherichiacoliiandistaphylococcusaureusibiofilmformation
AT jacopoforte effectofciprofloxacinloadedniosomesoniescherichiacoliiandistaphylococcusaureusibiofilmformation
AT mariagraziaammendolia effectofciprofloxacinloadedniosomesoniescherichiacoliiandistaphylococcusaureusibiofilmformation
AT patrizianadiahanieh effectofciprofloxacinloadedniosomesoniescherichiacoliiandistaphylococcusaureusibiofilmformation
AT antoniettaluciaconte effectofciprofloxacinloadedniosomesoniescherichiacoliiandistaphylococcusaureusibiofilmformation
AT michelarelucenti effectofciprofloxacinloadedniosomesoniescherichiacoliiandistaphylococcusaureusibiofilmformation
AT orlandodonfrancesco effectofciprofloxacinloadedniosomesoniescherichiacoliiandistaphylococcusaureusibiofilmformation
AT caterinaricci effectofciprofloxacinloadedniosomesoniescherichiacoliiandistaphylococcusaureusibiofilmformation
AT federicarinaldi effectofciprofloxacinloadedniosomesoniescherichiacoliiandistaphylococcusaureusibiofilmformation
AT carlottamarianecci effectofciprofloxacinloadedniosomesoniescherichiacoliiandistaphylococcusaureusibiofilmformation
AT mariacarafa effectofciprofloxacinloadedniosomesoniescherichiacoliiandistaphylococcusaureusibiofilmformation
AT catialonghi effectofciprofloxacinloadedniosomesoniescherichiacoliiandistaphylococcusaureusibiofilmformation